Title
Category
Credits
Event date
Cost
- Disease management
- 1.25 ACPE - Pharmacists
- 1.25 ACPE - Pharmacy Technicians
- 1.25 AMA - Physicians
- 1.25 ANCC - Nurses
- 1.25 APA - Psychologists
- 1.25 Attendance - General Attendance
- 1.25 CDR - Dietitians
- 1.25 ASWB - Social Workers
$0.00
This session will provide a comprehensive overview of the latest advancements in dementia care, including updates in screening methods, management strategies, and the critical role of multidisciplinary teams. Participants will learn about new diagnostic tools and promising blood tests for early detection. The session will also cover recent developments in pharmacological treatments and non-pharmacological interventions. Emphasis will be placed on the importance of coordinated care involving various healthcare professionals to optimize patient outcomes and quality of life.
- Disease management
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CDR - Dietitians
- 1.00 ASWB - Social Workers
$0.00
This activity will explore the ways in which artificial intelligence (AI) can improve organ allocation and transplantation medicine. This session will delve into how AI-driven algorithms enhance organ-matching precision, help predict transplant outcomes and optimize postoperative care. Participants will gain insight into the practical integration of AI into transplant practices, learn innovative strategies, and discuss real-world examples that demonstrate improved patient care and improve transplant success rates.
- Disease management
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 Attendance - General Attendance
09/17/2025
$0.00
This live webcast is designed to enhance primary care providers’ understanding of the evolving landscape of heart failure classification and treatment. Participants will explore the current nomenclature for heart failure staging and functional classification, with a focus on stratification by ejection fraction. The session will review the latest guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), including updates on pharmacologic and device-based interventions. Additionally, common barriers to implementing optimal therapy will be discussed, along with practical strategies to improve adherence and patient outcomes.